Skip to content

Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy

Effect of Intraoperative Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05705050
Enrollment
50
Registered
2023-01-30
Start date
2023-02-15
Completion date
2023-06-19
Last updated
2023-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aminophylline, Pain, Ureterocopic Lithotripsy

Keywords

Aminophylline, Postoperative Pain, Ureterocopic Lithotripsy

Brief summary

This study will be conducted to evaluate the effect of intraoperative systemic aminophylline infusion on pain intensity in patients undergoing ureteroscopic lithotripsy surgeries with ureteric stent placement at the end of the procedure.

Interventions

Patients will receive 4 mg/kg aminophylline diluted in 100 ml normal saline over 20 minutes after induction of anesthesia and positioning of patients in lithotomy position.

OTHERControl group

Patients will receive 100 ml normal saline over 20 minutes after induction and lithotomy positioning.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 to 50 years * American society of anesthesiology (ASA) physical status I - II * Body mass index (BMI) less than 30.0 kg/m2 * Scheduled for ureteroscopic lithotripsy surgery with D-J ureteric stent placement at the end of procedure * Under general anesthesia.

Exclusion criteria

1. Patients with central nervous system diseases, cardiovascular diseases, arrhythmias, cerebrovascular diseases, convulsions, renal impairment or hepatic dysfunction. 2. Pregnancy or lactation. 3. Patients with a history of allergy to aminophylline. 4. Coffee consumption (more than 2 cups/day) 5. Patients with opioid addiction or patients treated with B agonists, tranquilizers, or antidepressants. 6. Short procedures less than 30 minutes or procedures not requiring D-J stent placement.

Design outcomes

Primary

MeasureTime frameDescription
Intensity of painIn post anesthesia care unit (PACU)Visual analogue score (VAS) score: will be measured on arrival to PACU, at 30 minutes, 1 hour, 2 hour, 6, 12 and 24 hour after surgery.

Secondary

MeasureTime frameDescription
Intensity of pain24 hour after surgeryVisual analogue score (VAS) score: will be measured on arrival to PACU, at 30 minutes, 1 hour, 2 hour, 6, 12 and 24 hour after surgery.
Total amount of opioid dose24 hour after surgeryIf Patients reported VAS score more than 3, they will receive intravenous 0.5 mg /kg pethidine. All patients will be observed in PACU for at least 2 hour and in the ward on the day of surgery for confirming any side effects or complications.
The incidence of postoperative adverse reactions24 hour after surgerythe incidence of adverse reactions, such as arrhythmia, postoperative nausea and vomiting (PONV) and postoperative lightheadedness will be recorded in both groups.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026